ConductScience.org, home

Paper41548856

Avenues for optimization of cardiac therapeutics by minimally invasive delivery.

Li Y and 3 others. Acta Biomater, 2026. Cited by 3 papers, by iCite.

Cite this record

ConductScience Library. Avenues for optimization of cardiac therapeutics by minimally invasive delivery. Papers, record 41548856. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41548856

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Avenues for optimization of cardiac therapeutics by minimally invasive delivery.
PubMed
Journal
Acta Biomater
PubMed
Year
2026
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
3
iCite
Revised in PubMed
2026-09-20
PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Li YYuan
2Menasché PPhilippe
3Vunjak-Novakovic GGordana
4Cheng KKe

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

Grants6

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
R01 HL146153NHLBI NIH HHSUnited StatesR01HL146153PubMedNIH RePORTER
R01 HL144002NHLBI NIH HHSUnited StatesR01HL144002PubMedNIH RePORTER
R01 HL076485NHLBI NIH HHSUnited StatesR01HL076485PubMedNIH RePORTER
P41 EB027062NIBIB NIH HHSUnited StatesP41EB027062PubMedNIH RePORTER
R01 HL154154NHLBI NIH HHSUnited StatesR01HL154154PubMedNIH RePORTER
R01 HL170612NHLBI NIH HHSUnited StatesR01HL170612PubMedNIH RePORTER

Download CSV of grants

References217

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
124700706
Five-year outcomes in patients with left main disease treated with either percutaneous coronary intervention or coronary artery bypass grafting in the synergy between percutaneous coronary intervention with taxus and cardiac surgery trial.
Circulation2014https://conductscience.org/library/papers/24700706PubMed
233500578Targeted delivery of therapeutic agents to the heart.Nat Rev Cardiol2021https://conductscience.org/library/papers/33500578PubMed
328267588
Initial international multicenter human experience with a novel epicardial access needle embedded with a real-time pressure/frequency monitoring to facilitate epicardial access: Feasibility and safety.
Heart Rhythm2017https://conductscience.org/library/papers/28267588PubMed
438885303Advanced Cardiac Patches for the Treatment of Myocardial Infarction.Circulation2024https://conductscience.org/library/papers/38885303PubMed
535077739Delivery of modified mRNA to damaged myocardium by systemic administration of lipid nanoparticles.J Control Release2022https://conductscience.org/library/papers/35077739PubMed
634793116Extruded Mesenchymal Stem Cell Nanovesicles Are Equally Potent to Natural Extracellular Vesicles in Cardiac Repair.ACS Appl Mater Interfaces2021https://conductscience.org/library/papers/34793116PubMed
726375005Epicardial FSTL1 reconstitution regenerates the adult mammalian heart.Nature2015https://conductscience.org/library/papers/26375005PubMed
811980678Phase 1/2 placebo-controlled, double-blind, dose-escalating trial of myocardial vascular endothelial growth factor 2 gene transfer by catheter delivery in patients with chronic myocardial ischemia.Circulation2002https://conductscience.org/library/papers/11980678PubMed
912169644Differentiation of pluripotent embryonic stem cells into cardiomyocytes.Circ Res2002https://conductscience.org/library/papers/12169644PubMed
1027668147Injectable Hydrogels for Cardiac Tissue Repair after Myocardial Infarction.Adv Sci (Weinh)2015https://conductscience.org/library/papers/27668147PubMed
1128875984Multiscale technologies for treatment of ischemic cardiomyopathy.Nat Nanotechnol2017https://conductscience.org/library/papers/28875984PubMed
1225119045A long noncoding RNA protects the heart from pathological hypertrophy.Nature2014https://conductscience.org/library/papers/25119045PubMed
1340306855Delaying Drug Release: A Time Capsule for the Heart.JACC Basic Transl Sci2025https://conductscience.org/library/papers/40306855PubMed
1428596337Cardiac regeneration strategies: Staying young at heart.Science2017https://conductscience.org/library/papers/28596337PubMed
1528045024Therapeutic microparticles functionalized with biomimetic cardiac stem cell membranes and secretome.Nat Commun2017https://conductscience.org/library/papers/28045024PubMed
1633627421Injectable hydrogel with MSNs/microRNA-21-5p delivery enables both immunomodification and enhanced angiogenesis for myocardial infarction therapy in pigs.Sci Adv2021https://conductscience.org/library/papers/33627421PubMed
1727324127Cardiac fibrosis in myocardial infarction-from repair and remodeling to regeneration.Cell Tissue Res2016https://conductscience.org/library/papers/27324127PubMed
1829330085Inflammation following acute myocardial infarction: Multiple players, dynamic roles, and novel therapeutic opportunities.Pharmacol Ther2018https://conductscience.org/library/papers/29330085PubMed
1939831819Extracellular vesicle-mediated VEGF-A mRNA delivery rescues ischaemic injury with low immunogenicity.Eur Heart J2025https://conductscience.org/library/papers/39831819PubMed
2037192972Therapeutic angiogenesis based on injectable hydrogel for protein delivery in ischemic heart disease.iScience2023https://conductscience.org/library/papers/37192972PubMed

See all 217 referencesDownload CSV of references

Cited by3

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 3 citations.

PMIDTitleJournalYearIn PapersSource
42445832Controlled Delivery of Gasotransmitters for Cardiovascular Therapy: Molecular Mechanisms, Engineered Platforms, and Translational Perspectives.Int J Nanomedicine2026https://conductscience.org/library/papers/42445832PubMed
42403926Immune cell-derived membrane nanovesicles: A promethean fire for autoimmune disease therapy through immune cell mimicry.Bioact Mater2026https://conductscience.org/library/papers/42403926PubMed
42166700Intrapericardially injected hydrogel loaded with stromal cell secretome microparticles improves post-infarction myocardial repair in pigs.Eur Heart J2026https://conductscience.org/library/papers/42166700PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/41548856

GET https://conductscience.org/api/papers/v1/41548856/references?page=2